OTO-201 for the Treatment of Otitis Externa

Completed · Phase 2

Conditions studied: Otitis Externa

In brief

This is a 1-month, multicenter, open-label study in subjects with unilateral otitis externa. Eligible subjects will receive a single dose of 6 mg OTO-201 to the affected ear. The study is designed to characterize safety, procedural factors and clinical effect of OTO-201 administered in subjects with otitis externa.

Key facts

Study ID

NCT02511561

Run by

Otonomy, Inc.

People needed

75

Starts

2015-07-01

Expected to finish

2015-11-01

Last updated by the study team

2020-10-19

Who can join

Age: 1 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Email Otonomy Central Contact for Trial Locations — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.